Related Experiment Video
Updated: Mar 10, 2026

Assessment of Child Anthropometry in a Large Epidemiologic Study
Published on: February 2, 2017
Obesity and hypertensive heart disease: focus on body composition and sex differences
Giovanni de Simone1, Costantino Mancusi1, Raffaele Izzo1
1Hypertension Research Center, Federico II University Hospital, Via S. Pansini 5, Building 1, 80131 Naples, Italy ; Department of Translational Medical Sciences, Federico II University Hospital, Naples, Italy.
Insights
Obesity and hypertension in youth can lead to harmful left ventricular (LV) hypertrophy (LVH). Body composition, not just blood pressure, significantly impacts LVH development, especially in women.
Area of Science:
- Cardiology
- Obesity Research
- Hypertension Studies
Background:
- Hypertension and overweight/obesity are common in children and adolescents, both contributing to left ventricular (LV) hypertrophy (LVH).
- Obesity typically causes eccentric LV geometry (balanced growth), while hypertension is linked to concentric LV geometry (thickened walls).
- Concentric LV geometry, the most detrimental pattern, becomes more prevalent in obese individuals with age and in obese-hypertensive patients.
Approach:
- Investigated the influence of body composition and hemodynamic factors on LV geometry in obese-hypertensive individuals.
- Examined the role of severe obstructive sleep apnea and masked hypertension in developing concentric LV geometry.
- Analyzed the impact of adipose mass and fat-free mass on LV mass, particularly in women.
Key Points:
- Concentric LV geometry, a harmful pattern, increases with age in obese individuals and is frequent in obese-hypertensive patients.
- Non-hemodynamic factors, specifically body composition, play a crucial role in the prevalence of concentric LV geometry.
- Adipose mass significantly influences LV mass, especially in women with lower fat-free mass.
Conclusions:
- While blood pressure control is vital for managing LVH in obese hypertensive patients, reducing visceral adiposity is essential for LVH regression.
- Further research is needed to understand the prognostic implications of body composition-driven LVH versus pressure overload LVH.
- Future studies should focus on tissue characterization of hypertrophic hearts in obese-hypertensive patients and the utility of hemodynamic/biomarker assessments for management.
Abstract:
There is evidence that hypertension is frequently associated with overweight/obesity even in kids and adolescents. Either conditions influence development of left ventricular (LV) hypertrophy (LVH), through different biological and hemodynamic mechanisms: obesity is conventionally thought to elicit a coherent growth of LV chamber dimensions and myocardial wall thickness (eccentric LV geometry), whereas a more accentuated increase in wall-thickness (concentric LV geometry) is attributed to hypertension. While during youth these differences are visible, proportion of LV concentric geometry, the most harmful LV geometric pattern, sharply raises in obese individuals during middle age, and becomes the most frequent geometric patterns among obese-hypertensive individuals. Two conditions with elevated hemodynamic impact, severe obstructive sleep apnea and masked hypertension contribute to the development of such a geometric pattern, but non-hemodynamic factors, and specifically body composition, also influence prevalence of concentric LV geometry. Contrasting a general belief, it has been observed that adipose mass strongly influences LV mass, particularly in women, especially when fat-free mass is relatively deficient. Thus, though blood pressure control is mandatory for prevention and reduction of LVH in obese hypertensive patients, without reduction of visceral adiposity regression of LVH is difficult. Future researches should be addressed on (1) assessing whether LVH resulting from alteration of body composition carries the same prognosis as pressure overload LVH; (2) defining tissue characterization of the hypertrophic heart in obese-hypertensive patients; (3) evaluating whether assessment of hemodynamic loading conditions and biological markers can help defining management of the association of obesity with hypertension.
Related Concept Videos
Drug Dosing: Obese Patients
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity
Hypertension and Regulation of Blood Pressure
Hypertension II: Pathophysiology
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

